3/19/24 14:30 | 3/15/24 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S | -300 | 6.00 | 0 | -50 | -5 | 984 | D | | | | | | | | | | | | | | |
3/12/24 13:45 | 3/8/24 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S | -130 | 5.19 | 0 | -25 | -2 | 1,034 | D | | | | | | | | | | | | | | |
6/10/22 17:26 | 6/8/22 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | P.d | 44 | 0.9600 | 0 | 46 | 5 | 883 | D | | | | | | | | | | | | | | |
2/10/21 20:17 | 2/9/21 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S.m | -236 | 6.75 | 0 | -35 | -4 | 837 | D | | | | | | | | | | | | | | |
2/9/21 16:00 | 2/8/21 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S | -265 | 6.50 | 0 | -41 | -4 | 872 | D | | | | | | | | | | | | | | |
7/2/20 16:00 | 6/30/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 913 | D | | | | | | | | | | | | | | |
6/2/20 17:14 | 5/31/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 2 | 913 | D | | | | | | | | | | | | | | |
5/11/20 16:15 | 5/8/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S | -200 | 5.00 | 0 | -40 | -4 | 902 | D | | | | | | | | | | | | | | |
5/4/20 16:05 | 4/14/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S.m | -308 | 3.85 | 0 | -80 | -8 | 942 | D | | | | | | | | | | | | | | |
5/1/20 16:05 | 4/29/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | S | -180 | 4.50 | 0 | -40 | -4 | 1,022 | D | | | | | | | | | | | | | | |
4/2/20 16:16 | 3/31/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,062 | D | | | | | | | | | | | | | | |
3/3/20 19:38 | 2/29/20 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,062 | D | | | | | | | | | | | | | | |
1/2/20 16:15 | 12/31/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,044 | D | | | | | | | | | | | | | | |
12/2/19 16:56 | 11/30/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,044 | D | | | | | | | | | | | | | | |
10/2/19 16:33 | 9/30/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,044 | D | | | | | | | | | | | | | | |
9/3/19 18:09 | 8/31/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,044 | D | | | | | | | | | | | | | | |
7/2/19 16:30 | 6/30/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,036 | D | | | | | | | | | | | | | | |
6/3/19 16:15 | 5/31/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,036 | D | | | | | | | | | | | | | | |
4/1/19 16:40 | 3/31/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,028 | D | | | | | | | | | | | | | | |
3/1/19 17:23 | 2/28/19 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,028 | D | | | | | | | | | | | | | | |
1/3/19 17:30 | 12/31/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,020 | D | | | | | | | | | | | | | | |
12/11/18 17:41 | 12/10/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | P | 8 | 7.78 | 0 | 1 | 0 | 1,020 | D | | | | | | | | | | | | | | |
12/10/18 17:47 | 12/6/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | P | 17 | 8.69 | 0 | 2 | 0 | 1,019 | D | | | | | | | | | | | | | | |
12/4/18 16:05 | 11/30/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,017 | D | | | | | | | | | | | | | | |
11/26/18 13:43 | 11/21/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | P | 10 | 10.25 | 0 | 1 | 0 | 1,009 | D | | | | | | | | | | | | | | |
10/2/18 16:37 | 9/30/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 0 | 0 | 1,008 | D | | | | | | | | | | | | | | |
9/5/18 17:39 | 8/31/18 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schobel Alexander Mark | NJ | O | Chief In | M.d | 0 | 0.00 | 0 | 15 | 1 | 1,008 | D | | | | | | | | | | | | | | |